Larimar Therapeutics (LRMR) EBITDA (2013 - 2025)
Larimar Therapeutics' EBITDA came in at -$63.93 million for Q4 2025, compared with -$31.22 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) EBITDA (2013 - 2025) Analysis & Trends
For FY2025, Larimar Therapeutics' EBITDA was -$172.15 million.
- Going back by year, EBITDA was -$90.57 million in FY2024, -$41.45 million in FY2023, -$36.21 million in FY2022 and -$50.14 million in FY2021.
- The Q4 2025 figure represents the lowest quarterly EBITDA in data going back to Q3 2013.
- Business Quant data shows LRMR's EBITDA at -$49.41 million (Q3 2025), -$27.71 million (Q2 2025) and -$31.1 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Larimar Therapeutics | 252.95 Mn | -354.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -64.09 Mn |
| Sep 30, 2025 | -49.74 Mn |
| Jun 30, 2025 | -28.17 Mn |
| Mar 31, 2025 | -31.86 Mn |
| Dec 31, 2024 | -32.40 Mn |
| Sep 30, 2024 | -19.90 Mn |
| Jun 30, 2024 | -26.29 Mn |
| Mar 31, 2024 | -17.24 Mn |
| Dec 31, 2023 | -14.71 Mn |
| Sep 30, 2023 | -10.83 Mn |
| Jun 30, 2023 | -9.57 Mn |
| Mar 31, 2023 | -8.18 Mn |
| Dec 31, 2022 | -11.07 Mn |
| Sep 30, 2022 | -8.50 Mn |
| Jun 30, 2022 | -8.61 Mn |
| Mar 31, 2022 | -8.81 Mn |
| Dec 31, 2021 | -9.00 Mn |
| Sep 30, 2021 | -16.63 Mn |
| Jun 30, 2021 | -12.50 Mn |
| Mar 31, 2021 | -12.01 Mn |
API Access
Larimar Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();